GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SpectraScience Inc (GREY:SCIE) » Definitions » Cyclically Adjusted Price-to-FCF

SpectraScience (SpectraScience) Cyclically Adjusted Price-to-FCF : (As of May. 17, 2024)


View and export this data going back to . Start your Free Trial

What is SpectraScience Cyclically Adjusted Price-to-FCF?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted Price-to-FCF for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


SpectraScience Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for SpectraScience's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SpectraScience Cyclically Adjusted Price-to-FCF Chart

SpectraScience Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

SpectraScience Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of SpectraScience's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, SpectraScience's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SpectraScience's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SpectraScience's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where SpectraScience's Cyclically Adjusted Price-to-FCF falls into.



SpectraScience Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

SpectraScience's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2017 is calculated as:

For example, SpectraScience's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2017 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Sep. 2017 (Change)*Current CPI (Sep. 2017)
=-0/104.1356*104.1356
=0.000

Current CPI (Sep. 2017) = 104.1356.

SpectraScience Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
200712 -0.010 88.616 -0.012
200803 -0.017 90.090 -0.020
200806 -0.017 92.320 -0.019
200809 -0.015 92.307 -0.017
200812 -0.013 88.697 -0.015
200903 -0.012 89.744 -0.014
200906 -0.008 91.003 -0.009
200909 -0.007 91.120 -0.008
200912 -0.010 91.111 -0.011
201003 -0.010 91.821 -0.011
201006 -0.007 91.962 -0.008
201009 -0.008 92.162 -0.009
201012 -0.003 92.474 -0.003
201103 -0.005 94.283 -0.006
201106 -0.006 95.235 -0.007
201109 -0.010 95.727 -0.011
201112 -0.010 95.213 -0.011
201203 -0.010 96.783 -0.011
201206 -0.008 96.819 -0.009
201209 -0.004 97.633 -0.004
201212 -0.003 96.871 -0.003
201303 -0.003 98.209 -0.003
201306 -0.002 98.518 -0.002
201309 -0.002 98.790 -0.002
201312 -0.003 98.326 -0.003
201403 -0.004 99.695 -0.004
201406 -0.003 100.560 -0.003
201409 -0.004 100.428 -0.004
201412 -0.003 99.070 -0.003
201503 -0.003 99.621 -0.003
201506 -0.002 100.684 -0.002
201509 -0.003 100.392 -0.003
201512 -0.001 99.792 -0.001
201603 -0.001 100.470 -0.001
201606 -0.001 101.688 -0.001
201609 -0.001 101.861 -0.001
201612 0.000 101.863 0.000
201703 0.000 102.862 0.000
201706 0.000 103.349 0.000
201709 0.000 104.136 0.000

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


SpectraScience  (GREY:SCIE) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


SpectraScience Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of SpectraScience's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


SpectraScience (SpectraScience) Business Description

Traded in Other Exchanges
N/A
Address
11568-11 Sorrento Valley Road, San Diego, CA, USA, 92121
SpectraScience Inc is a US based company focused on developing the WavSTAT Optical Biopsy System (WavSTAT). The WavSTAT employs a risk technology that optically illuminates tissue in real-time to distinguish between normal and pre-cancerous or cancerous tissue. The firm has developed a technology platform to determine if the tissue is normal, pre-cancerous or cancerous, without the need for a physical biopsy. The WavSTAT operates by using cool, safe UV laser light to optically illuminate and analyze tissue, enabling the physician to make a diagnosis during endoscopy when screening for cancer and, if warranted, to begin treatment during the same procedure. The group sells its product in the United States and Europe, of which majority of the sales revenue is derived from the United States.
Executives
Lowell Giffhorn officer: CFO 10875 KEMAH LANE, SAN DIEGO CA 92131
John Pappajohn director 1660 WALT WHITMAN ROAD, SUITE 105, MELVILLE NY 11747
Euclidsr Partners, L.p. 10 percent owner 45 ROCKEFELLER PLAZA, SUITE 3240, NEW YORK NY 10111
Euclidsr Associates, L.p. 10 percent owner 45 ROCKEFELLER PLAZA, SUITE 3240, NEW YORK NY 10111
Tommy G Thompson director 7711 CARONDELET, ST. LOUIS MO 63105

SpectraScience (SpectraScience) Headlines

No Headlines